Vyome Holdings, Inc
HIND- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001427570
No open-market purchases or sales by Vyome Holdings, Inc insiders were filed in the last 90 days; 12 institutions reported holding it in 13F filings for Q2 2026, worth $296.5K in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Vyome Holdings, Inc as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 18
- +3 vs. Q2 2021
- Shares held
- 660.5K
- −386.1K (−36.9%) vs. Q2 2021
- Total value
- $1.90M
- −$3.33M (−63.7%) vs. Q2 2021
- New holders
- 9
- 6 more added
- Sold out
- 6
- 2 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting HIND on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 12 | $296.5K |
| Q1 2026 | 9 | $198.3K |
| Q4 2025 | 8 | $322.3K |
| Q3 2025 | 5 | $125.4K |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 1 | $1 |
| Q4 2024 | 1 | $13 |
| Q3 2024 | 2 | $24 |
| Q2 2024 | 16 | $73.3K |
| Q1 2024 | 18 | $49.1K |
| Q4 2023 | 15 | $108.3K |
| Q3 2023 | 17 | $134.7K |
| Q2 2023 | 11 | $153.5K |
| Q1 2023 | 13 | $370.3K |
| Q4 2022 | 10 | $12.2K |
| Q3 2022 | 23 | $237.0K |
| Q2 2022 | 19 | $744.0K |
| Q1 2022 | 17 | $1.45M |
| Q4 2021 | 15 | $1.91M |
| Q3 2021 | 18 | $1.90M |
| Q2 2021 | 15 | $5.23M |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Vyome Holdings, Inc; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Price T Rowe Associates Inc | 135,700 | $391.0K | 0.00% | +135,700 | New |
| Morgan Stanley | 105,265 | $303.0K | 0.00% | +105,261+2,631,525.0% | Added |
| Susquehanna Fundamental Investments, LLC | 95,100 | $274.0K | 0.01% | +95,100 | New |
| Virtu Financial LLC | 71,681 | $206.0K | 0.02% | +71,681 | New |
| Geode Capital Management, LLC | 69,389 | $199.0K | 0.00% | +46,112+198.1% | Added |
| Vanguard Group Inc | 55,376 | $159.0K | 0.00% | +4,256+8.3% | Added |
| Two Sigma Investments, LP | 40,255 | $116.0K | 0.00% | +40,255 | New |
| XTX Topco Ltd | 26,951 | $78.0K | 0.03% | +26,951 | New |
| State Street Corp | 19,600 | $56.0K | 0.00% | −90,399−82.2% | Reduced |
| Mid Atlantic Financial Management Inc | 10,000 | $29.0K | 0.00% | +10,000 | New |
| Sassicaia Capital Advisers LLC | 10,000 | $29.0K | 0.08% | +10,000 | New |
| Bank of America Corp | 9,595 | $28.0K | 0.00% | +9,595 | New |
| Signaturefd, LLC | 8,000 | $23.0K | 0.00% | +8,000 | New |
| Advisor Group Holdings, Inc. | 1,515 | $5.00K | 0.00% | +221+17.1% | Added |
| Tower Research Capital LLC (TRC) | 1,842 | $5.00K | 0.00% | +1,767+2,356.0% | Added |
| UBS Group AG | 122 | $0 | 0.00% | −2,709−95.7% | Reduced |
| Group One Trading, L.P. | 112 | $0 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 42 | $0 | 0.00% | +24+133.3% | Added |
| Armistice Capital, LLC | 0 | $0 | 0.00% | −816,527−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −24,188−100.0% | Sold out |
| Alpine Global Management, LLC | 0 | $0 | 0.00% | −17,000−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −167−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Salem Investment Counselors Inc | 0 | $0 | 0.00% | −4−100.0% | Sold out |